Literature DB >> 17245627

The influence of gallbladder function on the symptomatology in gallstone patients, and the outcome after cholecystectomy or expectancy.

Thomas Kjaergaard Larsen1, Niels Qvist.   

Abstract

The purpose of this study was to examine whether gallbladder function as assessed by a hepatobiliary scintigraphy was related to the symptomatology in gallstone patients and to the outcome 1 year after either cholecystectomy or watchful waiting. The study included 100 patients with uncomplicated gallstone disease. Fifty-six patients had a functioning gallbladder and 44 had a nonfunctioning gallbladder. Patients with a nonfunctioning gallbladder had significantly more vomiting and received more pain-killing injections during pain attacks. Otherwise, there were no differences in pain patterns or characteristics of dyspeptic symptoms in relation to gallbladder function. In patients with a functioning gallbladder, there were no significant differences between the group of patients with impaired and normal gallbladder function. Cholecystectomy was performed in 69 patients and at the 1-year follow-up; 22% continued to have pain attacks, but this was not related to the gallbladder function preoperatively. In 31 patients without cholecystectomy, 14 patients became asymptomatic within a 1-year follow-up. However, this was not related to gallbladder function. In conclusion, gallbladder function evaluated by a hepatobiliary scintigraphy was not related to the symptoms in gallstone patients, and was not related to the occurrence of symptoms after cholecystectomy or watchful waiting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245627     DOI: 10.1007/s10620-006-9498-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  19 in total

1.  Gallbladder contraction in patients with pigment and cholesterol stones.

Authors:  J Behar; K Y Lee; W R Thompson; P Biancani
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

2.  Preoperative prediction model of outcome after cholecystectomy for symptomatic gallstones.

Authors:  L Borly; I B Anderson; L Bardram; E Christensen; A Sehested; H Kehlet; P Matzen; J F Rehfeld; P Stage; D B Toftdahl; A Gernow; L Højgaard
Journal:  Scand J Gastroenterol       Date:  1999-11       Impact factor: 2.423

3.  Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.

Authors:  D Festi; R Frabboni; F Bazzoli; A Sangermano; M Ronchi; L Rossi; P Parini; M Orsini; A M Primerano; G Mazzella
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

4.  Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients.

Authors:  Jian Zhu; Tian-Quan Han; Sheng Chen; Yu Jiang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  Common pathogenetic mechanisms in symptomatic, uncomplicated gallstone disease and functional dyspepsia: volume measurement of gallbladder and antrum using three-dimensional ultrasonography.

Authors:  T Hausken; K Søndenaa; S Svebak; O H Gilja; S Olafsson; S Odegaard; O Søreide; A Berstad
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

6.  Usefulness of gallbladder ejection fraction estimation to predict the recurrence of biliary pain in patients with symptomatic gallstones who did not undergo cholecystectomy.

Authors:  Sung Noh Hong; Jong Kyun Lee; Kyu Taek Lee; Jin Seok Heo; Seong Ho Choi; Poong Lyul Rhee; Seung Woon Paik; Byung Chul Yoo; Jong Chul Rhee
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

7.  Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis.

Authors:  R P Jazrawi; P Pazzi; M L Petroni; N Prandini; C Paul; J A Adam; S Gullini; T C Northfield
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

8.  Pain patterns after distension of the gallbladder in patients with acute cholecystitis.

Authors:  H V Middelfart; P Jensen; L Højgaard; P Funch-Jensen
Journal:  Scand J Gastroenterol       Date:  1998-09       Impact factor: 2.423

9.  Correlation between gall bladder fasting volume and postprandial emptying in patients with gall stones and healthy controls.

Authors:  J Pauletzki; M Cicala; J Holl; T Sauerbruch; A Schafmayer; G Paumgartner
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

10.  Is biliary pain exclusively related to gallbladder stones? A controlled prospective study.

Authors:  Marjolein Y Berger; Tim C Olde Hartman; Jurgen J I M van der Velden; Arthur M Bohnen
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386

View more
  3 in total

1.  Gallbladder function and dynamics of bile flow in asymptomatic gallstone disease.

Authors:  Sevim Süreyya Cerçi; Feride Meltem Ozbek; Celal Cerçi; Bahattin Baykal; Hasan Erol Eroğlu; Zeynep Baykal; Mustafa Yildiz; Semahat Sağlam; Ahmet Yeşildağ
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

Review 2.  Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis.

Authors:  Miriam Brazzelli; Moira Cruickshank; Mary Kilonzo; Irfan Ahmed; Fiona Stewart; Paul McNamee; Andy Elders; Cynthia Fraser; Alison Avenell; Craig Ramsay
Journal:  Surg Endosc       Date:  2014-08-14       Impact factor: 4.584

3.  Protocol for a randomised controlled trial comparing laparoscopic cholecystectomy with observation/conservative management for preventing recurrent symptoms and complications in adults with uncomplicated symptomatic gallstones (C-Gall trial).

Authors:  Irfan Ahmed; Karen Innes; Miriam Brazzelli; Katie Gillies; Rumana Newlands; Alison Avenell; Rodolfo Hernández; Jane Blazeby; Bernard Croal; Jemma Hudson; Graeme MacLennan; Kirsty McCormack; Alison McDonald; Peter Murchie; Craig Ramsay
Journal:  BMJ Open       Date:  2021-03-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.